CIK 0001464521 · <br>Emerging growth company
Heartflow, Inc.
Sign in to watch- Ticker
- HTFL
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 260506743
- Phone
- 650-241-1221
- Business address
- 135 MAIN STREET, SUITE 1000, SAN FRANCISCO, CA, 94105
- Former names
- Cardiovascular Simulation, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $16,602,722
- in 13 filings, $16.6M under 10b5-1 plans
Net −$16,602,722. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-10 | Farquhar John C.M. Chief Executive Officer | Sale 10b5-1 | −22,562 | $28.50 | $643K | 496,835 |
| 2026-05-18 | Rogers Campbell Chief Medical Officer | Option exercise 10b5-1 | +9,219 | $19.00 | $175K | 87,950 |
| 2026-05-18 | Rogers Campbell Chief Medical Officer | Sale 10b5-1 | −9,219 | $28.34 | $261K | 78,731 |
| 2026-05-18 | Rogers Campbell Chief Medical Officer | Option exercise · Stock Options 10b5-1 | −9,219 | 101,410 | ||
| 2026-05-11 | Farquhar John C.M. Chief Executive Officer | Sale 10b5-1 | −22,562 | $29.12 | $657K | 519,397 |
| 2026-05-07 | Jones Marie L. Chief Accounting Officer | Shares withheld for taxes | −82 | $29.98 | $2K | 31,083 |
| 2026-05-07 | Rogers Campbell Chief Medical Officer | Shares withheld for taxes | −637 | $29.98 | $19K | 78,731 |
| 2026-05-07 | Verghese Vikram Chief Financial Officer | Shares withheld for taxes | −473 | $29.98 | $14K | 210,854 |
| 2026-05-07 | Farquhar John C.M. Chief Executive Officer | Shares withheld for taxes | −1,904 | $29.98 | $57K | 541,959 |
| 2026-05-06 | Jones Marie L. Chief Accounting Officer | Shares withheld for taxes | −485 | $30.29 | $15K | 31,165 |
| 2026-05-06 | Rogers Campbell Chief Medical Officer | Shares withheld for taxes | −1,634 | $30.29 | $49K | 79,368 |
| 2026-05-06 | Verghese Vikram Chief Financial Officer | Shares withheld for taxes | −1,536 | $30.29 | $47K | 211,327 |
| 2026-05-06 | Farquhar John C.M. Chief Executive Officer | Shares withheld for taxes | −5,300 | $30.29 | $161K | 543,863 |
| 2026-04-30 | Bain Capital Life Sciences Investors, LLC 10% owner | Sale | −892,533 | $29.18 | $26.0M | 8,504,382 |
| 2026-04-30 | Bain Capital Life Sciences Investors, LLC 10% owner | Sale | −56,224 | $30.05 | $1.7M | 8,448,158 |
| 2026-04-29 | Bain Capital Life Sciences Investors, LLC 10% owner | Sale | −797,133 | $29.37 | $23.4M | 9,396,915 |
| 2026-04-28 | Bain Capital Life Sciences Investors, LLC 10% owner | Sale | −254,110 | $30.51 | $7.8M | 10,194,048 |
| 2026-04-10 | Farquhar John C.M. Chief Executive Officer | Sale 10b5-1 | −22,562 | $26.72 | $603K | 549,163 |
| 2026-04-01 | Rogers Campbell Chief Medical Officer | Option exercise 10b5-1 | +291 | $8.33 | $2K | 78,809 |
| 2026-04-01 | Rogers Campbell Chief Medical Officer | Option exercise 10b5-1 | +19,111 | $2.22 | $42K | 97,920 |
Page 5 of 12 · 224 trades